Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma.

Autor: Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori - IRCCS Fondazione 'G. Pascale,' Napoli, Italy., Mandalà M; Department of Oncologic, Hematologic, Gastroenterological Sciences, University of Perugia, Perugia, Italy.; Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy., Ferrucci PF; Oncology Department Director, Ospedale San Giuseppe, MultiMedica Group, IRCCS, Milan., Guidoboni M; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori 'Dino Amadori,' Meldola, Italy., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska Curie National Research Institute of Oncology, 02-781, Warsaw, Poland., Ferraresi V; Sarcomas and Rare Tumors Departmental Unit, IRCCS Regina Elena National Cancer Institute, Rome., Arance A; Department of Medical Oncology and IDIBAPS, Hospital Clínic Barcelona, Barcelona., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori 'Giovanni Paolo II,' Bari, Italy., Maiello E; Oncology Unit, Foundation IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Gogas H; First Department of Medicine, National and Kapodistrian University of Athens, Athens., Richtig E; Department of Dermatology, Medical University of Graz, Graz, Austria., Quaglino P; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy., Lebbé C; Université Paris Cite, Dermato-Oncology and CIC AP-HP Hôpital Saint Louis, Cancer Institute APHP, Nord-Université Paris Cite, INSERM U976, Paris., Helgadottir H; Department of Oncology-Pathology, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm., Queirolo P; Skin Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Division of Melanoma, Sarcomas and Rare Tumors, IRCCS European Institute of Oncology, Milan., Spagnolo F; Skin Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genova, Italy., Tucci M; Department of Interdisciplinary Medicine, Oncology Unit, University of Bari 'Aldo Moro,' Bari, Italy., Del Vecchio M; Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan., Gonzalez-Cao M; Department of Medical Oncology, Oncology Institute Rosell, University Hospital Dexeus, Barcelona., Minisini AM; Academic Hospital 'Santa Maria della Misericordia,' Azienda Sanitaria Universitaria del Friuli Centrale, Udine, Italy., De Placido S; Department of Clinical Medicine and Surgery, University of Naples 'Federico II,' Naples, Italy., Sanmamed MF; Department of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Casula M; Immuno-Oncology & Targeted Cancer Biotherapies, Unit of Cancer Genetics, University of Sassari, IRGB-CNR, 07100 Sassari, Italy., Bulgarelli J; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori 'Dino Amadori,' Meldola, Italy., Pisano M; Immuno-Oncology & Targeted Cancer Biotherapies, Unit of Cancer Genetics, University of Sassari, IRGB-CNR, 07100 Sassari, Italy., Piccinini C; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori 'Dino Amadori,' Meldola, Italy., Piccin L; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Cossu A; Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy., Mallardo D; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori - IRCCS Fondazione 'G. Pascale,' Napoli, Italy., Paone M; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori - IRCCS Fondazione 'G. Pascale,' Napoli, Italy., Vitale MG; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori - IRCCS Fondazione 'G. Pascale,' Napoli, Italy., Melero I; Department of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Grimaldi AM; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori - IRCCS Fondazione 'G. Pascale,' Napoli, Italy.; Medical Oncology Unit, AORN San Pio, Benevento, Italy., Giannarelli D; Facility of Epidemiology and Biostatistics, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome., Palmieri G; Immuno-Oncology & Targeted Cancer Biotherapies, Unit of Cancer Genetics, University of Sassari, IRGB-CNR, 07100 Sassari, Italy., Dummer R; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Sileni VC; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.

Publikováno v: NEJM evidence [NEJM Evid] 2024 Oct; Vol. 3 (10), pp. EVIDoa2400087. Date of Electronic Publication: 2024 Sep 24.

First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax).

Autor: Ridolfi L; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers, Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Gurrieri L; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers, Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Riva N; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers, Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Bulgarelli J; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers, Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., De Rosa F; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers, Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Guidoboni M; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers, Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Fausti V; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers, Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Ranallo N; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers, Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Calpona S; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers, Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Tazzari M; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers, Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Petrini M; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers, Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Granato AM; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers, Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Pancisi E; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers, Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Foca F; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori' Meldola, Meldola, Italy., Dall'Agata M; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori' Meldola, Meldola, Italy., Bondi I; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori' Meldola, Meldola, Italy., Amadori E; Radiology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori' Meldola, Meldola, Italy., Cortesi P; Cardioncology Division, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Zani C; Pharmacy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Ancarani V; Experimental and Clinical Oncology of Immunotherapy and Rare Cancers, Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Gamboni A; Department of Oncology and Hematology AUSL Romagna, Lugo, Italy., Polselli A; Oncology Department Cattolica Hospital, Cattolica, Italy., Pasini G; Oncology Department Rimini Hospital, Rimini, Italy., Bartolini D; Pathology Unit, 'Maurizio Bufalini' Hospital, Cesena, Italy., Maimone G; Neurosurgery Unit Maurizio Bufalini Hospital, Cesena, Italy., Arpa D; Radiotherapy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Tosatto L; Neurosurgery Unit Maurizio Bufalini Hospital, Cesena, Italy.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Aug 13; Vol. 15, pp. 1404861. Date of Electronic Publication: 2024 Aug 13 (Print Publication: 2024).

Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.

Autor: Pallocca M; Institute of Experimental Endocrinology and Oncology, National Research Council, Naples, Italy. matteo.pallocca@ifo.it., Molineris I; Department of Life Science and System Biology, University of Turin, Via Accademia Albertina 13, 10123, Turin, Italy.; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Berrino E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; University of Turin, Turin, Italy., Marcozzi B; Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Betti M; Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Levati L; Laboratory of Molecular Oncology, IDI-IRCCS, Rome, Italy., D'Atri S; Laboratory of Molecular Oncology, IDI-IRCCS, Rome, Italy., Menin C; Immunology and Oncological Molecular Diagnostics, Oncological Institute, IOV IRCCS UOC, Padua, Italy., Madonna G; Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131, Naples, Italy., Ghiorzo P; Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.; Department of Internal Medicine and Medical Specialties, University of Genova, 16132, Genoa, Italy., Bulgarelli J; Immunotherapy, Cell Therapy and Biobank Unit, IRCCS Istituto Romagnolo Per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014, Meldola, Italy., Ferraresi V; Sarcoma and Rare Tumours Departmental Unit- IRCCS Regina Elena National Cancer Institute-Rome, Rome, Italy., Venesio T; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Rodolfo M; Unit of Translational Immunology, Department of Experimental Oncology, IRCCS Foundation National Cancer Institute, Milan, Italy., Rivoltini L; Unit of Translational Immunology, Department of Experimental Oncology, IRCCS Foundation National Cancer Institute, Milan, Italy., Lanfrancone L; Department of Experimental Oncology, European Institute of Oncology IRCCS (IEO), Milan, Italy., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131, Naples, Italy., Mazzarella L; Department of Experimental Oncology, European Institute of Oncology IRCCS (IEO), Milan, Italy., Pelicci PG; Department of Experimental Oncology, European Institute of Oncology IRCCS (IEO), Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., De Maria R; Institute of General Pathology, Catholic University 'Sacro Cuore', Rome, Italy., Ciliberto G; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Medico E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Russo G; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.

Publikováno v: Journal of translational medicine [J Transl Med] 2024 Jan 06; Vol. 22 (1), pp. 29. Date of Electronic Publication: 2024 Jan 06.

49P Exploiting multi-omic integrated data from DC-vaccinated melanoma patients for the generation of an advanced adoptive T cell therapy

Autor: Bulgarelli, J., Tazzari, M., Carloni, S., Pignatta, S., Bochicchio, M.T., Bocchini, M., Angeli, D., Tebaldi, M., Granato, A.M., Piccinini, C., Pancisi, E., F. de Rosa, Ancarani, V., Limarzi, F., Petrini, M., Ridolfi, L.

Publikováno v: In Immuno-Oncology and Technology December 2022 16 Supplement 1

Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series.

Autor: Gurrieri L; Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P. Maroncelli 40, 47014, Meldola, Italy., Mercatali L; Preclinic and Osteoncology Unit, Bioscience Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014, Meldola, Italy., Ibrahim T; Osteoncology, Bone and Soft Tissue Sarcomas, and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, 40138, Bologna, Italy., Fausti V; Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P. Maroncelli 40, 47014, Meldola, Italy. valentina.fausti@irst.emr.it., Dall'Agata M; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014, Meldola, Italy., Riva N; Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P. Maroncelli 40, 47014, Meldola, Italy., Ranallo N; Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P. Maroncelli 40, 47014, Meldola, Italy., Pasini G; Department of Medical Oncology, 'Infermi' Hospital, 47921, Rimini, Italy., Tazzari M; Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P. Maroncelli 40, 47014, Meldola, Italy., Foca F; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014, Meldola, Italy., Bartolini D; Pathology Unit, 'Maurizio Bufalini' Hospital, 47521, Cesena, Italy., Riccioni L; Pathology Unit, 'Maurizio Bufalini' Hospital, 47521, Cesena, Italy., Cavatorta C; Pathology Unit, 'Maurizio Bufalini' Hospital, 47521, Cesena, Italy., Morigi FP; Pathology Unit, 'Maurizio Bufalini' Hospital, 47521, Cesena, Italy., Bulgarelli J; Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P. Maroncelli 40, 47014, Meldola, Italy., Cocchi C; Preclinic and Osteoncology Unit, Bioscience Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014, Meldola, Italy., Ghini V; Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P. Maroncelli 40, 47014, Meldola, Italy., Tosatto L; Neurosurgery, 'Maurizio Bufalini' Hospital, 47521, Cesena, Italy., Martinelli G; Scientific Direcrorate, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014, Meldola, Italy., Pession A; Division of Pediatrics, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, 40138, Bologna, Italy., Ridolfi L; Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P. Maroncelli 40, 47014, Meldola, Italy.

Publikováno v: Journal of neuro-oncology [J Neurooncol] 2023 Aug; Vol. 164 (1), pp. 55-64. Date of Electronic Publication: 2023 Aug 16.